Fig. 6From: Chemoresistant ovarian cancer enhances its migration abilities by increasing store-operated Ca2+ entry-mediated turnover of focal adhesionsSOCE inhibitors decrease migration ability of chemoresistant IGROV1 cells in transwell assay. In vitro transwell migration assay was performed to evaluate the effect of SOCE inhibitors (2 μΜ SKF-96365, 10 μΜ YM-58483, 0.1 μM 2-APB) on chemoresistant IGROV1 (CP, SRT) cells. a, c Representative photomicrographs of (a) IGROV1-CP and (c) IGROV1-SRT cells that penetrated a filter of pore size of 8 μm. Scale bars, 200 μm. b, d Migrated (b) IGROV1-CP and (d) IGROV1-SRT cells were counted in 15 random fields on the lower surface of the filters and expressed as percentage (%) of SOCE inhibitor pretreated cells compared with DMSO control (Ctrl). Each bar represents mean ± SEM from three independent experiments. *: significant difference between cells treated with SOCE inhibitors and DMSO control (Ctrl). *: p < 0.05; **: p < 0.01; ***: p < 0.001 by Student’s t-testBack to article page